turn.bio Company
Turn.bio is developing therapies to effectively return mature differentiated cells to a dramatically younger state
Industry:
Gene Therapy
Headquarters:
California, United States
Founded Date:
Feb 2019
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
5
Estimated Revenue:
Less than $1M
Last Funding Date:
Apr 28, 2021
Last Funding Type:
Funding Round
Register and Claim Ownership